Director Lead Dissolution

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function

Discovery & Pre-Clinical/Clinical Development

Job Sub Function

Pharmaceutical Product R&D

Job Category

People Leader

All Job Posting Locations:

Beerse, Antwerp, Belgium

Job Description

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

Position Summary

Johnson & Johnson Innovative Medicine is recruiting for a Director, DISSO — Dissolution and In Vitro Release Sciences, Simulations and Optimization, located in Beerse, Belgium.

The Director will lead the DISSO team within Synthetics Analytical Development. The team plays a critical role in developing, validating, transferring, and applying dissolution and in vitro release methods to support Drug Product Research & Development across the synthetic portfolio, from early development through registration and commercial lifecycle support.

This role requires a strong scientific and people leader with deep expertise in dissolution science, biopharmaceutics-relevant testing, analytical control strategy, laboratory operations, and product performance understanding. The successful candidate will provide strategic and scientific direction to the DISSO organization, ensure a state-of-the-art and cGMP-compliant laboratory environment, and strengthen interfaces across Analytical Development, Drug Product Research & Development, Chemical Process R&D, Regulatory Affairs, Quality, Supply Chain, and the AD India organization.

As a member of the Analytical Development Leadership Team, the Director will contribute to shaping the future strategy, capabilities, talent base, operating model, and culture of Synthetics Analytical Development. The role will also build and align DISSO strategies with the AD India team, where late-stage dissolution and analytical activities are executed under the leadership of the AD India lead.

The role includes accountability for leading a team of approximately 30 J&J employees, supported by contractor resources, and for ensuring effective stewardship of people, laboratory capabilities, and financial resources, including FTE planning, OPEX, CAPEX, and out-of-pocket investments required to maintain a state-of-the-art, cGMP-compliant DISSO laboratory and enable delivery of the synthetic portfolio.

Key Responsibilities

• Lead the DISSO team and provide scientific, strategic, operational, and people leadership for dissolution and in vitro release sciences within Synthetics Analytical Development.
• Lead a sizeable scientific organization, including approximately 30 J&J employees, supported by contractor resources. Provide clear scientific direction, people leadership, resource prioritization, and capability development across the DISSO organization.
• Serve as a member of the Analytical Development Leadership Team, contributing to the future direction, organizational strategy, talent development, capability agenda, and operating model of Synthetics Analytical Development.
• Define and drive dissolution strategies across the synthetic drug product portfolio, ensuring phase-appropriate, scientifically sound, and regulatory-compliant approaches from early development through registration and lifecycle management.
• Build and align DISSO strategies with the AD India team, ensuring clear interfaces, effective knowledge transfer, and robust execution of late-stage dissolution and analytical activities under the leadership of the AD India lead.
• Ensure state-of-the-art laboratory capabilities and cGMP compliance, including robust laboratory practices, inspection readiness, equipment strategy, data integrity, method execution